Neonatal alloimmune thrombocytopaenia associated with maternal HLA antibodies

Neonatal alloimmune thrombocytopaenia (NAIT) generally results from platelet opsonisation by maternal antibodies against fetal platelet antigens inherited from the infant’s father. Newborn monochorionic twins presented with petechial haemorrhages at 10 hours of life, along with severe thrombocytopae...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:BMJ case reports 2017-07, Vol.2017, p.bcr-2016-218269
Hauptverfasser: Wendel, Kristina, Akkök, Çiğdem Akalin, Kutzsche, Stefan
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page bcr-2016-218269
container_title BMJ case reports
container_volume 2017
creator Wendel, Kristina
Akkök, Çiğdem Akalin
Kutzsche, Stefan
description Neonatal alloimmune thrombocytopaenia (NAIT) generally results from platelet opsonisation by maternal antibodies against fetal platelet antigens inherited from the infant’s father. Newborn monochorionic twins presented with petechial haemorrhages at 10 hours of life, along with severe thrombocytopaenia. Despite the initial treatment with platelet transfusions and intravenous immunoglobulin, they both had persistent thrombocytopaenia during their first 45 days of life. Class I human leucocyte antigen (HLA) antibodies with broad specificity against several HLA-B antigens were detected in the maternal serum. Weak antibodies against HLA-B57 and HLA-B58 in sera from both twins supported NAIT as the most likely diagnosis. Platelet transfusion requirements of the twins lasted for 7 weeks. Transfusion of HLA-matched platelet concentrates was more efficacious to manage thrombocytopaenia compared with platelet concentrates from random donors. Platelet genotyping and determination of HLA antibody specificity are needed to select compatible platelet units to expedite safe recovery from thrombocytopaenia in NAIT.
doi_str_mv 10.1136/bcr-2016-218269
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5534834</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1916709292</sourcerecordid><originalsourceid>FETCH-LOGICAL-b3719-a8ba6f776743d167a0d71350ec9f20cf230f72b4c4acfdc9419c44bccbedbb1b3</originalsourceid><addsrcrecordid>eNqFkc9r2zAUx0XpaEva827D0EsZuNEvW9ZlEErbFNL10sFu4kmWFwXbSiW7Jf_9FJyVbpfpogf6vC_v6YPQZ4KvCWHlXJuQU0zKnJKKlvIInRFRiFxI_PP4Q32KLmLc4HQY4RVnJ-iUVqWQBcFn6PG79T0M0GbQtt513djbbFgH32lvdoPfgu0dZBCjNw4GW2dvblhnXSpDn7qWq0UG_eC0r52N5-hTA220F4d7hn7c3T7fLPPV0_3DzWKVayaIzKHSUDZClIKzmpQCcC0IK7A1sqHYNJThRlDNDQfT1EZyIg3n2hhta62JZjP0bcrdjrqztbH9EKBV2-A6CDvlwam_X3q3Vr_8qyoKxivGU8DVISD4l9HGQXUuGtu20Fs_RkVkGgtLKmlCL_9BN37c7z5RWFbp9xM1nygTfIzBNu_DEKz2tlSypfa21GQrdXz5uMM7_8dNAr5OgO42_037DUzOn0c</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1916098182</pqid></control><display><type>article</type><title>Neonatal alloimmune thrombocytopaenia associated with maternal HLA antibodies</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><creator>Wendel, Kristina ; Akkök, Çiğdem Akalin ; Kutzsche, Stefan</creator><creatorcontrib>Wendel, Kristina ; Akkök, Çiğdem Akalin ; Kutzsche, Stefan</creatorcontrib><description>Neonatal alloimmune thrombocytopaenia (NAIT) generally results from platelet opsonisation by maternal antibodies against fetal platelet antigens inherited from the infant’s father. Newborn monochorionic twins presented with petechial haemorrhages at 10 hours of life, along with severe thrombocytopaenia. Despite the initial treatment with platelet transfusions and intravenous immunoglobulin, they both had persistent thrombocytopaenia during their first 45 days of life. Class I human leucocyte antigen (HLA) antibodies with broad specificity against several HLA-B antigens were detected in the maternal serum. Weak antibodies against HLA-B57 and HLA-B58 in sera from both twins supported NAIT as the most likely diagnosis. Platelet transfusion requirements of the twins lasted for 7 weeks. Transfusion of HLA-matched platelet concentrates was more efficacious to manage thrombocytopaenia compared with platelet concentrates from random donors. Platelet genotyping and determination of HLA antibody specificity are needed to select compatible platelet units to expedite safe recovery from thrombocytopaenia in NAIT.</description><identifier>ISSN: 1757-790X</identifier><identifier>EISSN: 1757-790X</identifier><identifier>DOI: 10.1136/bcr-2016-218269</identifier><identifier>PMID: 28679510</identifier><language>eng</language><publisher>England: BMJ Publishing Group LTD</publisher><subject>Accuracy ; Age ; Antibodies - blood ; Antigens ; Antigens, Human Platelet - blood ; Blood ; Blood platelets ; Blood Platelets - metabolism ; Case reports ; Data collection ; Europe (West) ; Female ; Flow cytometry ; Genotype ; HLA-B Antigens - blood ; Humans ; Immunoglobulins ; Immunoglobulins, Intravenous ; Indian sub-continent ; Infant, Newborn ; Maternal-Fetal Exchange ; Neonate ; Newborn babies ; Platelet Transfusion ; Pregnancy ; Reminder of Important Clinical Lesson ; Thrombocytopenia, Neonatal Alloimmune - blood ; Thrombocytopenia, Neonatal Alloimmune - diagnosis ; Thrombocytopenia, Neonatal Alloimmune - etiology ; Thrombocytopenia, Neonatal Alloimmune - therapy ; Twins</subject><ispartof>BMJ case reports, 2017-07, Vol.2017, p.bcr-2016-218269</ispartof><rights>BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.</rights><rights>Copyright: 2017 © BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.</rights><rights>BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted. 2017</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b3719-a8ba6f776743d167a0d71350ec9f20cf230f72b4c4acfdc9419c44bccbedbb1b3</citedby><cites>FETCH-LOGICAL-b3719-a8ba6f776743d167a0d71350ec9f20cf230f72b4c4acfdc9419c44bccbedbb1b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5534834/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5534834/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,27903,27904,53769,53771</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28679510$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wendel, Kristina</creatorcontrib><creatorcontrib>Akkök, Çiğdem Akalin</creatorcontrib><creatorcontrib>Kutzsche, Stefan</creatorcontrib><title>Neonatal alloimmune thrombocytopaenia associated with maternal HLA antibodies</title><title>BMJ case reports</title><addtitle>BMJ Case Rep</addtitle><description>Neonatal alloimmune thrombocytopaenia (NAIT) generally results from platelet opsonisation by maternal antibodies against fetal platelet antigens inherited from the infant’s father. Newborn monochorionic twins presented with petechial haemorrhages at 10 hours of life, along with severe thrombocytopaenia. Despite the initial treatment with platelet transfusions and intravenous immunoglobulin, they both had persistent thrombocytopaenia during their first 45 days of life. Class I human leucocyte antigen (HLA) antibodies with broad specificity against several HLA-B antigens were detected in the maternal serum. Weak antibodies against HLA-B57 and HLA-B58 in sera from both twins supported NAIT as the most likely diagnosis. Platelet transfusion requirements of the twins lasted for 7 weeks. Transfusion of HLA-matched platelet concentrates was more efficacious to manage thrombocytopaenia compared with platelet concentrates from random donors. Platelet genotyping and determination of HLA antibody specificity are needed to select compatible platelet units to expedite safe recovery from thrombocytopaenia in NAIT.</description><subject>Accuracy</subject><subject>Age</subject><subject>Antibodies - blood</subject><subject>Antigens</subject><subject>Antigens, Human Platelet - blood</subject><subject>Blood</subject><subject>Blood platelets</subject><subject>Blood Platelets - metabolism</subject><subject>Case reports</subject><subject>Data collection</subject><subject>Europe (West)</subject><subject>Female</subject><subject>Flow cytometry</subject><subject>Genotype</subject><subject>HLA-B Antigens - blood</subject><subject>Humans</subject><subject>Immunoglobulins</subject><subject>Immunoglobulins, Intravenous</subject><subject>Indian sub-continent</subject><subject>Infant, Newborn</subject><subject>Maternal-Fetal Exchange</subject><subject>Neonate</subject><subject>Newborn babies</subject><subject>Platelet Transfusion</subject><subject>Pregnancy</subject><subject>Reminder of Important Clinical Lesson</subject><subject>Thrombocytopenia, Neonatal Alloimmune - blood</subject><subject>Thrombocytopenia, Neonatal Alloimmune - diagnosis</subject><subject>Thrombocytopenia, Neonatal Alloimmune - etiology</subject><subject>Thrombocytopenia, Neonatal Alloimmune - therapy</subject><subject>Twins</subject><issn>1757-790X</issn><issn>1757-790X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNqFkc9r2zAUx0XpaEva827D0EsZuNEvW9ZlEErbFNL10sFu4kmWFwXbSiW7Jf_9FJyVbpfpogf6vC_v6YPQZ4KvCWHlXJuQU0zKnJKKlvIInRFRiFxI_PP4Q32KLmLc4HQY4RVnJ-iUVqWQBcFn6PG79T0M0GbQtt513djbbFgH32lvdoPfgu0dZBCjNw4GW2dvblhnXSpDn7qWq0UG_eC0r52N5-hTA220F4d7hn7c3T7fLPPV0_3DzWKVayaIzKHSUDZClIKzmpQCcC0IK7A1sqHYNJThRlDNDQfT1EZyIg3n2hhta62JZjP0bcrdjrqztbH9EKBV2-A6CDvlwam_X3q3Vr_8qyoKxivGU8DVISD4l9HGQXUuGtu20Fs_RkVkGgtLKmlCL_9BN37c7z5RWFbp9xM1nygTfIzBNu_DEKz2tlSypfa21GQrdXz5uMM7_8dNAr5OgO42_037DUzOn0c</recordid><startdate>20170705</startdate><enddate>20170705</enddate><creator>Wendel, Kristina</creator><creator>Akkök, Çiğdem Akalin</creator><creator>Kutzsche, Stefan</creator><general>BMJ Publishing Group LTD</general><general>BMJ Publishing Group</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20170705</creationdate><title>Neonatal alloimmune thrombocytopaenia associated with maternal HLA antibodies</title><author>Wendel, Kristina ; Akkök, Çiğdem Akalin ; Kutzsche, Stefan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b3719-a8ba6f776743d167a0d71350ec9f20cf230f72b4c4acfdc9419c44bccbedbb1b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Accuracy</topic><topic>Age</topic><topic>Antibodies - blood</topic><topic>Antigens</topic><topic>Antigens, Human Platelet - blood</topic><topic>Blood</topic><topic>Blood platelets</topic><topic>Blood Platelets - metabolism</topic><topic>Case reports</topic><topic>Data collection</topic><topic>Europe (West)</topic><topic>Female</topic><topic>Flow cytometry</topic><topic>Genotype</topic><topic>HLA-B Antigens - blood</topic><topic>Humans</topic><topic>Immunoglobulins</topic><topic>Immunoglobulins, Intravenous</topic><topic>Indian sub-continent</topic><topic>Infant, Newborn</topic><topic>Maternal-Fetal Exchange</topic><topic>Neonate</topic><topic>Newborn babies</topic><topic>Platelet Transfusion</topic><topic>Pregnancy</topic><topic>Reminder of Important Clinical Lesson</topic><topic>Thrombocytopenia, Neonatal Alloimmune - blood</topic><topic>Thrombocytopenia, Neonatal Alloimmune - diagnosis</topic><topic>Thrombocytopenia, Neonatal Alloimmune - etiology</topic><topic>Thrombocytopenia, Neonatal Alloimmune - therapy</topic><topic>Twins</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wendel, Kristina</creatorcontrib><creatorcontrib>Akkök, Çiğdem Akalin</creatorcontrib><creatorcontrib>Kutzsche, Stefan</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>BMJ case reports</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wendel, Kristina</au><au>Akkök, Çiğdem Akalin</au><au>Kutzsche, Stefan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Neonatal alloimmune thrombocytopaenia associated with maternal HLA antibodies</atitle><jtitle>BMJ case reports</jtitle><addtitle>BMJ Case Rep</addtitle><date>2017-07-05</date><risdate>2017</risdate><volume>2017</volume><spage>bcr-2016-218269</spage><pages>bcr-2016-218269-</pages><issn>1757-790X</issn><eissn>1757-790X</eissn><abstract>Neonatal alloimmune thrombocytopaenia (NAIT) generally results from platelet opsonisation by maternal antibodies against fetal platelet antigens inherited from the infant’s father. Newborn monochorionic twins presented with petechial haemorrhages at 10 hours of life, along with severe thrombocytopaenia. Despite the initial treatment with platelet transfusions and intravenous immunoglobulin, they both had persistent thrombocytopaenia during their first 45 days of life. Class I human leucocyte antigen (HLA) antibodies with broad specificity against several HLA-B antigens were detected in the maternal serum. Weak antibodies against HLA-B57 and HLA-B58 in sera from both twins supported NAIT as the most likely diagnosis. Platelet transfusion requirements of the twins lasted for 7 weeks. Transfusion of HLA-matched platelet concentrates was more efficacious to manage thrombocytopaenia compared with platelet concentrates from random donors. Platelet genotyping and determination of HLA antibody specificity are needed to select compatible platelet units to expedite safe recovery from thrombocytopaenia in NAIT.</abstract><cop>England</cop><pub>BMJ Publishing Group LTD</pub><pmid>28679510</pmid><doi>10.1136/bcr-2016-218269</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1757-790X
ispartof BMJ case reports, 2017-07, Vol.2017, p.bcr-2016-218269
issn 1757-790X
1757-790X
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5534834
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central
subjects Accuracy
Age
Antibodies - blood
Antigens
Antigens, Human Platelet - blood
Blood
Blood platelets
Blood Platelets - metabolism
Case reports
Data collection
Europe (West)
Female
Flow cytometry
Genotype
HLA-B Antigens - blood
Humans
Immunoglobulins
Immunoglobulins, Intravenous
Indian sub-continent
Infant, Newborn
Maternal-Fetal Exchange
Neonate
Newborn babies
Platelet Transfusion
Pregnancy
Reminder of Important Clinical Lesson
Thrombocytopenia, Neonatal Alloimmune - blood
Thrombocytopenia, Neonatal Alloimmune - diagnosis
Thrombocytopenia, Neonatal Alloimmune - etiology
Thrombocytopenia, Neonatal Alloimmune - therapy
Twins
title Neonatal alloimmune thrombocytopaenia associated with maternal HLA antibodies
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T18%3A39%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Neonatal%20alloimmune%20thrombocytopaenia%20associated%20with%20maternal%20HLA%20antibodies&rft.jtitle=BMJ%20case%20reports&rft.au=Wendel,%20Kristina&rft.date=2017-07-05&rft.volume=2017&rft.spage=bcr-2016-218269&rft.pages=bcr-2016-218269-&rft.issn=1757-790X&rft.eissn=1757-790X&rft_id=info:doi/10.1136/bcr-2016-218269&rft_dat=%3Cproquest_pubme%3E1916709292%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1916098182&rft_id=info:pmid/28679510&rfr_iscdi=true